Get started
Author

Marianna Veraldi

Observed name: M Veraldi
Institution: Regione Calabria
ORCID: 0000-0002-4264-1522
Observed ORCID: 0000-0002-4264-1522
OpenAlex ID: A5013538468
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (“PEMBROREAL” Study)
2024 · Alessandro Cafaro, Flavia Foca, et al. · Cancers · 12
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)
2024 · Alessandro Cafaro, Flavia Foca, et al. · Frontiers in Oncology · 9
PDF
Real-world data on patients with metastatic non-small-cell lung cancer treated with checkpoint inhibitors in an Italian Teaching Hospital in 2015–2018
2020 · Marianna Veraldi, Stefania Esposito, et al. · Journal of Oncology Pharmacy Practice · 4
Impact of COVID-19 of oncology pharmacy services: Results of 8-months survey
2022 · Agnieszka Bienert, Klaus Meier, et al. · European Journal of Oncology Pharmacy · 2
Impact of COVID-19 on Mental Health of Oncology Health Care Workers and Interdisciplinary Collaboration: Results of Surveys in 2021 and 2022
2023 · Agnieszka Bienert, Klaus Meier, et al. · European Journal of Oncology Pharmacy · 1
5PSQ-152 Real world efficacy and cost data on patients with metastatic non-small cell lung cancer treated with checkpoint inhibitors in an Italian university hospital in September 2016–2020
2021 · M Veraldi, S Esposito, et al. · European Journal of Hospital Pharmacy
PDF
Microbiota intestinale, efficacia e tossicità delle terapie oncologiche
2020 · Marianna Veraldi, Nicola Nigri, et al. · Bollettino SIFO
Cardiotossicità dei farmaci anti-HER2 nel trattamento di carcinoma mammario metastatico: case-report
2020 · Marianna Veraldi, Stefania Esposito, et al. · Giornale italiano di farmacia clinica
Nuovi approcci della terapia intravitreale in oftalmologia: analisi della pratica clinica e valutazioni costo-efficacia
2020 · Ada Vero, Cristina Zito, et al. · Bollettino SIFO
Works count: 9
Citation count: 28
H-index: 3
I10-index: 1
Year
Topic
Type